Evidence map›Paper›PMID 17506678›Full record

ReviewAnnual review of microbiology2007

Morphogenesis in Candida albicans.

Malcolm Whiteway, Catherine Bachewich

Abstract readReview
In one paragraph

Review in Annual review of microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 213 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
213citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

213 citing papers in PubMed, 1 synthesis or guideline pooled it, 390 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. In Vitro Acid Resistance of PathogenicGastro hep advances · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Differential alteration inMicrobiology spectrum · 2024
    Article

153 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Malcolm WhitewayNational Research Council of Canada, Biotechnology Research Institute, Montreal, Quebec, H4P 2R2, Canada. Malcolm.Whiteway@cnrc-nrc.gc.ca
Catherine Bachewich
Concordia University · CAMcGill University · CA

Funding

CIHR 42516-3CIHR 79843-1
6 · The paper itself

Abstract

Candida albicans is termed a dimorphic fungus because it proliferates in either a yeast form or a hyphal form. The switch between these forms is the result of a complex interplay of external and internal factors and is coordinated in part by polarity-regulating proteins that are conserved among eukaryotic cells. However, yeast and hyphal cells are not the only morphological states of C. albicans. The opaque form required for mating, the pseudohyphal cell, and the chlamydospore represent distinct cell types that form in response to specific genetic or environmental conditions. In addition, hyperextended buds can form as a result of various cell cycle-related stresses. Recent studies are beginning to shed light on some of the molecular controls regulating the various morphogenetic forms of this fascinating human pathogen.

Indexed as

MorphogenesisCandida albicansCyclin-Dependent KinasesCyclinsHyphaePheromonesSignal TransductionSpores, FungalCyclin-Dependent KinasesCyclinsPheromones

Identifiers

PMID17506678
PMCPMC4452225
OpenAlexW2112243625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.